The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs

Zhao, Sizheng Steven ORCID: https://orcid.org/0000-0002-3558-7353, Harrison, Stephanie R, Thompson, Ben, Yates, Max, Eddison, Joe, Chan, Antoni, Clarke, Nick, Corp, Nadia, Davis, Charlotte, Felix, Lambert, Flora, Kalveer, Gregory, William J ORCID: https://orcid.org/0000-0002-1186-5806, Jones, Gareth T ORCID: https://orcid.org/0000-0003-0016-7591, Lamb, Christopher A, Marzo-Ortega, Helena ORCID: https://orcid.org/0000-0002-9683-3407, Murphy, Daniel J, Petrushkin, Harry, Sandhu, Virinderjit, Sengupta, Raj, Siebert, Stefan ORCID: https://orcid.org/0000-0002-1802-7311, Van Der Windt, Danielle A, Webb, Dale, Yiu, Zenas Z N and Gaffney, Karl ORCID: https://orcid.org/0000-0002-7863-9176 (2025) The 2025 British Society for Rheumatology guideline for the treatment of axial spondyloarthritis with biologic and targeted synthetic DMARDs. Rheumatology. ISSN 1462-0324

Preview

Published Version
Available under License Creative Commons Attribution.
Download (1MB) | Preview

Item Type:	Article (Article)
Peer-reviewed:	Yes
Date Deposited:	23 Apr 2025 08:25
Publisher:	Oxford University Press (OUP)
Additional Information:	This is an open access article which appeared in Rheumatology, published by Oxford University Press
Divisions:	Faculties > Health and Education > Health Professions
Subject terms:	extra-musculoskeletal manifestations, ankylosing spondylitis, management, psoriasis, recommendations, uveitis, targeted synthetic DMARDs, inflammatory bowel disease, axSpA, guideline, treatment, biologics
Data Access Statement:	All data are provided in online Supplementary Materials, available at Rheumatology online.
URI:	https://e-space.mmu.ac.uk/id/eprint/639624
DOI:	https://doi.org/10.1093/rheumatology/keaf089
ISSN	1462-0324

Activity Overview

6 month trend

2Downloads

6 month trend

6Hits

Additional statistics for this dataset are available via IRStats2.

Edit record